Inhibidores de la PARP en cáncer de mama con mutación BRCA

Previous Page

Next Page

Page Background

§

Molecular heterogeneity of TNBC

Ø

Toward Precision Medicine in gBRCAm BC

§

i-PARP in gBRCAm BC

Ø

Monoterapia:

Olympia EMBRACA ABRAZO

Ø

Con quimioterapia:

BROCADE BRIGHTNESS

§

Weakness of i-PARP?

§

NCCN Evidence Blocks™